Ventyx biosciences to host r&d event on january 26, 2023

Encinitas, calif., jan. 05, 2023 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that it will host an r&d event on thursday, january 26, 2023 in new york city from 9-11:30 a.m. et. the event will highlight key aspects of ventyx's clinical-stage and discovery programs.
VTYX Ratings Summary
VTYX Quant Ranking